Compound Detail
CHEMBL5429301
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5429301 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AJGORSAHCLHPNX-WYMLVPIESA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
338.4
MW (Da)
6.13
ALogP
3
HBA
0
HBD
31.0
PSA (Ų)
0.40
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.49
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HCT-116 | IC50 | = | 32100.0 | nM | 4.49 | Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability... | 37036951 |
| HepG2 | IC50 | = | 37700.0 | nM | 4.42 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i... | 37036951 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37036951 | 10.1021/acs.jmedchem.2c01808 | HepG2 | 1 |
| 37036951 | 10.1021/acs.jmedchem.2c01808 | HCT-116 | 1 |
| 37036951 | 10.1021/acs.jmedchem.2c01808 | NCM460 | 1 |
Data from ChEMBL 36 via Core Engine